Psychiatric blood biomarkers: Avoiding jumping to premature negative or positive conclusions

A. B. Niculescu, D. Levey, H. Le-Niculescu, E. Niculescu, S. M. Kurian, D. Salomon

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Blood biomarkers may provide a scientifically useful and clinically usable peripheral signal in psychiatry, as they have been doing for other fields of medicine. Jumping to premature conclusions, negative or positive, can create confusion in this field. Reproducibility is a hallmark of good science. We discuss some recent examples from this dynamic field, and show some new data in support of previously published biomarkers for suicidality (SAT1, MARCKS and SKA2). Methodological clarity and rigor in terms of biomarker discovery, validation and testing is needed. We propose a set of principles for what constitutes a good biomarker, similar in spirit to the Koch postulates used at the birth of the field of infectious diseases.

Original languageEnglish (US)
Pages (from-to)286-288
Number of pages3
JournalMolecular Psychiatry
Volume20
Issue number3
DOIs
StatePublished - Mar 12 2015

Fingerprint

Psychiatry
Biomarkers
Communicable Diseases
Medicine
Parturition

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Psychiatric blood biomarkers : Avoiding jumping to premature negative or positive conclusions. / Niculescu, A. B.; Levey, D.; Le-Niculescu, H.; Niculescu, E.; Kurian, S. M.; Salomon, D.

In: Molecular Psychiatry, Vol. 20, No. 3, 12.03.2015, p. 286-288.

Research output: Contribution to journalReview article

Niculescu, A. B. ; Levey, D. ; Le-Niculescu, H. ; Niculescu, E. ; Kurian, S. M. ; Salomon, D. / Psychiatric blood biomarkers : Avoiding jumping to premature negative or positive conclusions. In: Molecular Psychiatry. 2015 ; Vol. 20, No. 3. pp. 286-288.
@article{6e8f99baee684d6a82cb4a3b5cd21863,
title = "Psychiatric blood biomarkers: Avoiding jumping to premature negative or positive conclusions",
abstract = "Blood biomarkers may provide a scientifically useful and clinically usable peripheral signal in psychiatry, as they have been doing for other fields of medicine. Jumping to premature conclusions, negative or positive, can create confusion in this field. Reproducibility is a hallmark of good science. We discuss some recent examples from this dynamic field, and show some new data in support of previously published biomarkers for suicidality (SAT1, MARCKS and SKA2). Methodological clarity and rigor in terms of biomarker discovery, validation and testing is needed. We propose a set of principles for what constitutes a good biomarker, similar in spirit to the Koch postulates used at the birth of the field of infectious diseases.",
author = "Niculescu, {A. B.} and D. Levey and H. Le-Niculescu and E. Niculescu and Kurian, {S. M.} and D. Salomon",
year = "2015",
month = "3",
day = "12",
doi = "10.1038/mp.2014.180",
language = "English (US)",
volume = "20",
pages = "286--288",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Psychiatric blood biomarkers

T2 - Avoiding jumping to premature negative or positive conclusions

AU - Niculescu, A. B.

AU - Levey, D.

AU - Le-Niculescu, H.

AU - Niculescu, E.

AU - Kurian, S. M.

AU - Salomon, D.

PY - 2015/3/12

Y1 - 2015/3/12

N2 - Blood biomarkers may provide a scientifically useful and clinically usable peripheral signal in psychiatry, as they have been doing for other fields of medicine. Jumping to premature conclusions, negative or positive, can create confusion in this field. Reproducibility is a hallmark of good science. We discuss some recent examples from this dynamic field, and show some new data in support of previously published biomarkers for suicidality (SAT1, MARCKS and SKA2). Methodological clarity and rigor in terms of biomarker discovery, validation and testing is needed. We propose a set of principles for what constitutes a good biomarker, similar in spirit to the Koch postulates used at the birth of the field of infectious diseases.

AB - Blood biomarkers may provide a scientifically useful and clinically usable peripheral signal in psychiatry, as they have been doing for other fields of medicine. Jumping to premature conclusions, negative or positive, can create confusion in this field. Reproducibility is a hallmark of good science. We discuss some recent examples from this dynamic field, and show some new data in support of previously published biomarkers for suicidality (SAT1, MARCKS and SKA2). Methodological clarity and rigor in terms of biomarker discovery, validation and testing is needed. We propose a set of principles for what constitutes a good biomarker, similar in spirit to the Koch postulates used at the birth of the field of infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=84924649928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924649928&partnerID=8YFLogxK

U2 - 10.1038/mp.2014.180

DO - 10.1038/mp.2014.180

M3 - Review article

C2 - 25582618

AN - SCOPUS:84924649928

VL - 20

SP - 286

EP - 288

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 3

ER -